Polymorphism of regulators of apoptosis and growth factors genes in chronic lymphatic leukemia

Polymorphism of regulators of apoptosis and growth factors genes in chronic lymphatic leukemia

The objective of the research is to study the role of polymorphic variants of Tumor Necrosis Factor (TNF) — a (TNFA), Bcl2-associated X protein (BAX) p53-Binding Protein (MDM2), vascular endothelial growth factor (VEGFA) and basic fibroblast growth factor (bFGF) genes in chronic lymphocytic leukemia...

Full description

Bibliographic Details
Main Authors:	Viktorova T.V., Karimov D.O., Bakirov В.A.
Format:	Article
Language:	Russian
Published:	Saratov State Medical University 2011-12-01
Series:	Саратовский научно-медицинский журнал
Subjects:	chronic lymphocytic leukaemia genetic polymorphism oncogenesis genes
Online Access:	http://www.ssmj.ru/system/files/201104_827-831.pdf

Similar Items

Polymorphism of apoptosis regulatory and growth factor genes in patients with chronic lymphocytic leukemia
by: Bulat A. Bakirov, et al.
Published: (2012-06-01)

Chronic Lymphocytic Leukemia Presenting as Recurrent Pulmonary Infections
by: Sudhir Kumar Vujhini1 , Narendra Kumar Narahari2
Published: (2015-08-01)

Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy
by: Stefano Licci
Published: (2020-10-01)

Regularities of cytokine status changes in chronic lymphocytic leukaemia and their role in pathogenesis of progressive forms of disease
by: Shelekhova T.V., et al.
Published: (2012-06-01)

An incidental finding of chronic lymphocytic leukaemia in a patient with pulmonary tuberculosis
by: Victoria R. Parker, et al.
Published: (2020-12-01)

Chronic lymphocytic leukaemia: clinical-aetiological findings in 66 patients and their families
by: Weber Walter, et al.
Published: (2007-12-01)

An unusual presentation of Chronic Lymphocytic Leukaemia as delirium
by: N Manamohan, et al.
Published: (2017-01-01)

p53 expression in chronic lymphocytic leukaemia
by: Nasir AL-Allawi, et al.
Published: (2005-07-01)

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia
by: Bulian Pietro, et al.
Published: (2012-01-01)

Chronic Neutrophilic Leukemia with Monocytosis
by: Laila Alromaih, et al.
Published: (2021-05-01)

Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
by: Al-Sawaf O, et al.
Published: (2017-01-01)

Immunological features of lymphoid tumours
by: Hamblin, T. J.
Published: (1986)

Chronic lymphocytic leukaemia: An immunobiology approach
by: Kostareli Efterpi, et al.
Published: (2008-01-01)

Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia
by: Wysoczanska B, et al.
Published: (2019-05-01)

Polymorphism of Folate metabolism genes and risk of lung cancer
by: M. L. Bakanova, et al.
Published: (2019-04-01)

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
by: Didar Yanardag Acik, et al.
Published: (2019-11-01)

Association of MTHFR C677T and A1298C Polymorphisms with Susceptibility to Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis
by: Atefeh RAOUFI, et al.
Published: (2020-12-01)

Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia
by: Ahmet Mentese, et al.
Published: (2018-10-01)

Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis
by: Nuttall E, et al.
Published: (2019-07-01)

Leukaemia cutis for clinicians, a literature review
by: Małgorzata Osmola, et al.
Published: (2021-07-01)

Whipple's Disease as the First Manifestation of Chronic Lymphocytic Leukaemia
by: Verónica Botelho Guiomar, et al.
Published: (2019-09-01)

Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
by: Beatriz Jatobá Pimentel, et al.
Published: (2008-01-01)

An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects
by: Afaf Alharthi, et al.
Published: (2018-05-01)

ASSOCIATION OF DELETION 13Q14 WITH CLINICOPATHOLOGIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Ali Ahmed, et al.
Published: (2021-04-01)

COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia
by: Orivaldo Alves Barbosa, et al.
Published: (2020-06-01)

OVERCOMING IMMUNODEFICIENCY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: CURRENT KNOWLEDGE AND PERSPECTIVES
by: Fabienne McClanahan, et al.
Published: (2014-07-01)

CHRONIC LYMPHOCYTIC LEUKAEMIA: CENSUS OF PATIENTS TREATED IN ITALIAN HAEMATOLOGY UNITS
by: Gianfranco Salvi
Published: (2015-10-01)

Immune system parameters in chronic opisthorchiasis patients related to genes polymorphisms associated with developing ischemic heart disease
by: S. A. Grigoryeva, et al.
Published: (2021-02-01)

THE ROLE OF CD49D IN CHRONIC LYMPHOCYTIC LEUKAEMIA: MICROENVIRONMENTAL INTERACTIONS AND CLINICAL RELEVANCE
by: Michele Dal Bo, et al.
Published: (2014-07-01)

Haematological splenomegaly does not directly relate to portal hypertension: From a clinical study to surgical choice
by: Antonio Manenti, et al.
Published: (2017-06-01)

Chronic lymphocytic leukaemia trends and features at a tertiary hospital in South Africa (2011–2016)
by: Fungai Musaigwa, et al.
Published: (2021-06-01)

Stomach Cancer in a Patient with Chronic Lymphocytic Leukaemia
by: R. A. Maier, et al.
Published: (2019-07-01)

Effects of IL-2,IL-6,IL-7 and IFN on the proliferation,survival,induction and reduction of spontaneous in-vitro apoptosis of B CLL cells
by: Seahloli, Michael Sello
Published: (2007)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)

Prognostic significance of new biological markers in chronic lymphocytic leukaemia
by: Gotić Mirjana, et al.
Published: (2011-01-01)

Expression levels of the apoptosis genes FAS, TNFR2, TRAIL, DR3 and DR4/5 in patients with newly diagnosed chronic lymphatic leukemia before and after treatment with fludarabine, cyclophosphamide and rituximab (FCR)
by: S. G. Zakharov, et al.
Published: (2018-12-01)

Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
by: Kotnik Barbara Faganel, et al.
Published: (2017-09-01)

Chronic lymphocytic leukaemia: contemporary conceptions of etiology, pathogenesis and peculiarities of clinical manifestations (review)
by: Chesnokova N.P., et al.
Published: (2011-06-01)

Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
by: Lukáš Smolej, et al.
Published: (2021-06-01)

EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
by: Roberta Valsecchi, et al.
Published: (2020-05-01)